GeoVax Labs Inc (GOVX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | SHARKEY, JOHN W. | VP, Business Development | Stock Option | Acquisition | 17,600 | 0 |
| Jun 17, 2026 | LEMEROND, NICOLE | Director | Stock Option | Acquisition | 6,000 | 0 |
| Jun 17, 2026 | DODD, DAVID A | Director, President, CEO | Stock Option | Acquisition | 29,300 | 0 |
| Jun 17, 2026 | MCKEE, KELLY T. JR. | Chief Medical Officer | Stock Option | Acquisition | 17,600 | 0 |
| Jun 17, 2026 | KOLLINTZAS, DEAN G | Director | Stock Option | Acquisition | 6,000 | 0 |
| Jun 17, 2026 | CHASE, RANDAL D | Director | Stock Option | Acquisition | 6,000 | 0 |
| Jun 17, 2026 | NEWMAN, MARK J | Chief Scientific Officer | Stock Option | Acquisition | 17,600 | 0 |
| Jun 17, 2026 | MCNALLY, ROBERT T | Director | Stock Option | Acquisition | 6,000 | 0 |
| Jun 17, 2026 | MORGAN, JAYNE | Director | Stock Option | Acquisition | 6,000 | 0 |
| Jun 17, 2026 | REYNOLDS, MARK | CFO | Stock Option | Acquisition | 17,600 | 0 |
| Jun 17, 2026 | SPENCER, JOHN N JR | Director | Stock Option | Acquisition | 6,000 | 0 |
| Oct 17, 2025 | SPENCER, JOHN N JR | Director | Common Stock | Acquisition | 10,000 | 0.55 |